Hem/Onc Pharmacology Section 16- Imatinib, Dasatinib, Nilotinib, Erlotinib, Dabranefib, and Vemurafenib

TOPICS: Imatinib, dasatinib, nilotinib, bcr abl tyrosine kinase, cml, all, c-kit tyrosine kinase, gi stromal tumors, gist, fluid retention, periorbital edema, ankle edema, erlotinib, egfr inhibitor, non small cell lung cancer, pancreatic cancer, xerosis, acneiform rash, diarrhea, dabrafenib, vemurafenib, braf oncogene, serine threonine kinase, metastatic melanoma, nausea, vomiting
Go Back



Upgrade Now to Access All Content

Upgrade Now

Please register for a FREE account to get FREE access to all of our Microbiology videos.
CREATE FREE ACCOUNT